Stock Market Reviews

HSIC (Henry Schein, Inc.) News

Get the latest news, insights, and market updates on HSIC (Henry Schein, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• New Henry Schein CEO expected by mid-January as Bergman extends tenure
  Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the end of 2025.
  Jan 5, 2026 - $HSIC
• Henry Schein (NASDAQ:HSIC) Has More To Do To Multiply In Value Going Forward
  There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
  Dec 30, 2025 - $HSIC
• Henry Schein to Participate in the J.P. Morgan Conference in January
  MELVILLE, N.Y., December 29, 2025--Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in January:
  Dec 29, 2025 - $HSIC
• One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan
  An improving earnings profile, aggressive buybacks, and a renewed focus on margins might be changing how long-term investors think about this healthcare distributor.
  Dec 29, 2025 - $HSIC
• Henry Schein Provides Update on CEO Search Process
  MELVILLE, N.Y., December 23, 2025--Henry Schein, Inc. (Nasdaq: HSIC) (the "Company"), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint the Company’s next CEO by mid-January 2026.
  Dec 23, 2025 - $HSIC
• How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?
  Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.
  Dec 18, 2025 - $HSIC
• 3 Small-Cap Stocks We Steer Clear Of
  Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
  Dec 12, 2025 - $HSIC
• How Henry Schein’s (HSIC) Expanded Curodont Deal Could Reshape Its Technology-Enabled Margin Story
  Earlier this month, Henry Schein, Inc. announced an expanded agreement with Swiss firm vVARDIS, granting it exclusive U.S. distribution rights for the drill-free Curodont Repair Fluoride Plus cavity treatment across all dental market segments from January 1, 2026. This move deepens Henry Schein’s role in minimally invasive dental care by turning an underserved pool of early-stage cavity patients into a new treatment and revenue channel for practices. We’ll now examine how broader Curodont...
  Dec 10, 2025 - $HSIC
• Henry Schein, Inc. (HSIC): A Bull Case Theory
  We came across a bullish thesis on Henry Schein, Inc. on X.com by FullySynergized. In this article, we will summarize the bulls’ thesis on HSIC. Henry Schein, Inc.’s share was trading at $73.11 as of December 1st. HSIC’s trailing and forward P/E were 23.06 and 13.95 respectively according to Yahoo Finance. Henry Schein, Inc. (HSIC) is the largest […]
  Dec 9, 2025 - $HSIC
• Why Henry Schein (HSIC) Stock Is Up Today
  Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 2.8% in the afternoon session after Barclays initiated coverage on the company with an 'Overweight' rating and an $86 price target. The rating from the bank reflected a positive outlook on the company's potential for growth. Analyst Glen Santangelo announced the new coverage. Adding to the positive sentiment, Henry Schein also announced an extension of its strategic partnership with KKR. As part of the agreement, KKR
  Dec 9, 2025 - $HSIC